Clinical Trials Sponsored by Rachel Lieberman

Total 3599 results

Haukeland University Hospital
Hoffmann-La Roche; Bergen Prison, Norwegian Correctional Service

Terminated

Hepatitis C Treatment of Inmates (PEGPRI)

Chronic Hepatitis C

Norway
Austrian Breast & Colorectal Cancer Study Group
Hoffmann-La Roche; Sanofi-Synthelabo

Completed

Preoperative Combined Radiochemotherapy for Patients With Rectal Carcinoma

Rectal Cancer

Austria
H. Lee Moffitt Cancer Center and Research Institute
Roche Pharma AG

Completed

Study of Capecitabine With Irinotecan and Oxaliplatin (Eloxatin) in Advanced Colorectal Cancer

Colorectal Cancer

United States, Puerto Rico
Hoosier Cancer Research Network
Sanofi; Hoffmann-La Roche; Walther Cancer Institute

Terminated

Capecitabine, Oxaliplatin and Trastuzumab in Treating Patients With HER2 Positive Metastatic Breast Cancer

Metastatic Breast Cancer

United States
National Institute of Allergy and Infectious Diseases...
Hoffmann-La Roche

Completed

(Ro 24-2027) A Randomized, Double-Blind, Comparative Study of Dideoxycytidine (ddC) Versus Zidovudine (AZT) in Patients With AIDS or Advanced ARC

HIV Infections

United States
University of Ulm
Medac GmbH (Hamburg, Germany); Roche (Grenzach-Wyhlen, Germany)

Completed

Modulation of Adjuvant 5-FU by Folinic Acid and Interferon-alpha in Colon Cancer (FOGT1)

Rectal Cancer

Germany
The Korean Society of Hematopoietic Stem Cell Transplantation
Hoffmann-La Roche

Unknown

Study of Rituximab in Patients With Steroid-Refractory Chronic Graft-Versus-Host Disease

Steroid-Refractory Chronic GVHD

Korea, Republic of
National Institute of Allergy and Infectious Diseases...
Hoffmann-La Roche

Completed

A Study of Dideoxycytidine Plus Zidovudine in the Treatment of AIDS or Advanced AIDS Related Complex (ARC)

HIV Infections

United States
University of Edinburgh
Roche Educational Grant; Edinburgh Sick Kids Friends Foundation

Completed

Effect of an Integrated Care Pathway on Asthma Care in Hospital

Asthma

United Kingdom
Rahul Aggarwal
Janssen Scientific Affairs, LLC

Active, not recruiting

Apalutamide Plus Cetrelimab in Patients With Treatment-Emergent Small Cell Neuroendocrine Prostate Cancer

Prostate Cancer | Small Cell Carcinoma | Small Cell Neuroendocrine Carcinoma

United States
National Institute of Allergy and Infectious Diseases...
Hoffmann-La Roche

Completed

A Randomized Comparative Pharmacokinetic Study of Oral Ganciclovir After Treatment With Intravenous Ganciclovir for Cytomegalovirus Gastrointestinal Disease in AIDS Patients

HIV Infections | Colitis

United States
National Institute of Allergy and Infectious Diseases...
Hoffmann-La Roche

Completed

A Phase III Randomized Trial of Topical Vaginal Fluorouracil (5-Fluorouracil, 5-FU) Maintenance Therapy Versus Observation After Standard Treatment for High-Grade Cervical Dysplasia in HIV-Infected Women

HIV Infections | Cervix, Dysplasia

United States, Puerto Rico
National Institute of Allergy and Infectious Diseases...
Hoffmann-La Roche

Completed

Chemoprevention of Anal Neoplasia Arising Secondary to Anogenital Human Papillomavirus Infection in Persons With HIV Infection.

HIV Infections | Anus Neoplasms

United States
National Institute of Allergy and Infectious Diseases...
Hoffmann-La Roche

Completed

A Pilot Study Evaluating Penicillin G and Ceftriaxone as Therapies for Presumed Neurosyphilis in HIV Seropositive Individuals

HIV Infections | Neurosyphilis

United States
National Institute of Allergy and Infectious Diseases...
Hoffmann-La Roche

Completed

A Trial of Two Doses of 2',3'-Dideoxycytidine (ddC) in the Treatment of Children With Symptomatic HIV Infection Who Are Intolerant of AZT and/or Who Show Progressive Disease While on AZT

HIV Infections

United States, Puerto Rico
Ludwig-Maximilians - University of Munich
Hoffmann-La Roche; Janssen-Cilag G.m.b.H

Active, not recruiting

Combination of PCI-32765 With Obinutuzumab in Untreated Follicular Lymphoma (Alternative)

Indolent Non-Hodgkin Lymphoma

Germany
Rahul Aggarwal
National Cancer Institute (NCI)

Terminated

Magnetic Resonance (MR) Imaging With Hyperpolarized Pyruvate (HP) (13C) in Castration-Resistant Prostate Cancer (MR)

Prostate Cancer

United States
Grupo Español de Investigación en Cáncer de Ovario
Roche Pharma AG

Terminated

Neoadjuvant Therapy in Advanced Ovarian Cancer With Avastin (NOVA)

Cancer, Ovarian

Spain
Seng Gee Lim
Roche Pharma AG

Unknown

Peg-interferon for Inactive Chronic Hepatitis B Carriers (INACTIVE)

Chronic Hepatitis, B Virus | Carrier of Viral Hepatitis Type B

Singapore
Kristi G. Bache, PhD
Oslo University Hospital

Completed

The Norwegian Acute Stroke Prehospital Project (NASPP)

Traumatic Brain Injury | Acute Stroke

Norway
Peter Kozuch
Hoffmann-La Roche; Genentech, Inc.

Terminated

Study of the Antitumor Activity of Capecitabine in Combination With Erlotinib in Patients With Metastatic Colorectal Cancer

Metastatic Colorectal Cancer

United States
Dutch Colorectal Cancer Group
Sanofi; Hoffmann-La Roche; Koningin Wilhelmina Fonds

Unknown

Maintenance Treatment Versus Observation After Induction in Advanced Colorectal Carcinoma (CAIRO3)

Colorectal Cancer Metastatic

Netherlands
Association Tunisienne de lutte Contre le Cancer
Sanofi; Hoffmann-La Roche

Unknown

Efficacy and Safety of Bevacizumab in the Neodjuvant Treatment of Inflammatory Breast Cancer (Beva)

Inflammatory Breast Cancer

Tunisia
National Institute of Allergy and Infectious Diseases...
Hoffmann-La Roche

Completed

Dideoxycytidine ( Ro 24-2027 ) A Randomized, Open-Label, Comparative Study of Dideoxycytidine ( ddC ) Versus Zidovudine ( AZT ) in Patients With AIDS or Advanced ARC Who Have Received Long-Term AZT Therapy.

HIV Infections

United States
National Institute of Allergy and Infectious Diseases...
Hoffmann-La Roche

Completed

A Randomized Study of Activity, Safety, and Tolerance of Oral Ro 24-7429 (Tat Antagonist) in Patients With HIV Infection

HIV Infections

United States
Imagine Institute
RWTH Aachen University; Ruhr University of Bochum; Medical University of Warsaw

Recruiting

Clinical Trial Data Set Re-use With Statistical Methodologies Tailored for Clinical Trials in Rare Diseases (EPISTOPIDEAL)

Epilepsy | Tuberous Sclerosis

France
Hospital Sao Rafael
Ministry of Health, Brazil; Ministry of Science and Technology, Brazil

Unknown

Clinical Trial for Evaluation of Treatment With Multiple Infusions of Mononuclear Bone Marrow Cells in Patients With Chronic Liver Diseases

Hepatic Cirrhosis | Chronic Hepatitis

Brazil
NHS Greater Glasgow and Clyde
University of Glasgow; Roche Diagnostics GmbH

Not yet recruiting

Biomarkers for the Assessment of Congestion in Patients With Ambulatory and Hospitalised Heart Failure (BIO-CONGEST)

Heart Failure | Congestion

United Kingdom
Christoph Königs
Roche Pharma AG; Chugai Pharma Germany GmbH

Recruiting

Dynamics of the Anti-factor VIII Antibody Signature During Treatment With Emicizumab (NAVIGATE)

Severe Hemophilia A | Severe Hemophilia A With Inhibitor | Severe Hemophilia A Without Inhibitor

Germany
Wim Janssens
Roche Pharma AG; AstraZeneca; European Respiratory Society

Recruiting

The CATALINA Study

Chronic Obstructive Pulmonary Disease Exacerbation

Belgium, Spain, Sweden, Netherlands, France, Germany, Italy, United Kingdom
Rahul Aggarwal
National Cancer Institute (NCI)

Recruiting

Magnetic Resonance Imaging (MRI) With Hyperpolarized Pyruvate (13C) as Diagnostic Tool in Advanced Prostate Cancer

Prostate Cancer | Advanced Prostate Carcinoma

United States
Peter Liu
Ottawa Heart Institute Research Corporation; Roche Diagnostics; Genome Canada

Recruiting

Biomarker Guided Discharge of Heart Failure Patients (RADAR)

Heart Failure; With Decompensation

Canada
Hoffmann-La Roche
PPD; Laboratory Corporation of America; Illingworth Research Group

Active, not recruiting

A Study Evaluating B Cell Levels In Infants Of Lactating Women With CIS Or MS Receiving Ocrelizumab (SOPRANINO)

Multiple Sclerosis | Clinically Isolated Syndrome

United States, Spain, United Kingdom, Germany
Hoffmann-La Roche
National Institute on Aging (NIA); Banner Alzheimer's Institute

Completed

Tau Positron Emission Tomography (PET) Longitudinal Substudy Associated With: Study of Crenezumab Versus Placebo in Preclinical Presenilin1 (PSEN1) E280A Mutation Carriers in the Treatment of Autosomal-Dominant Alzheimer's Disease

Alzheimer Disease

Colombia
NCIC Clinical Trials Group
Roche Pharma AG

Completed

Adjuvant Erlotinib After Completing Chemoradiotherapy in Locally Advanced Squamous Cell Carcinoma of the Head and Neck

Head and Neck Cancer

Canada
Spanish Breast Cancer Research Group
Hoffmann-La Roche; German Breast Group

Completed

Bevacizumab + Endocrine Treatment vs Endocrine Treatment as First Line in Postmenopausal Women

Breast Cancer

Spain, Germany
Spanish Breast Cancer Research Group
Sanofi; Hoffmann-La Roche; Amgen; Cephalon

Completed

Neoadjuvant Chemotherapy With Myocet/Taxotere/Herceptin for HER2 Positive Breast Cancer Patients

Breast Cancer

Spain
Spanish Oncology Genito-Urinary Group
Roche Farma, S.A; Dynamic Science S.L.

Active, not recruiting

Efficacy of Atezolizumab Concurrent With Radiotherapy in Patients With Muscle-invasive Bladder cáncer

Bladder Cancer

Spain
National Institute of Allergy and Infectious Diseases...
Hoffmann-La Roche

Completed

The Safety and Effectiveness of Ganciclovir in the Prevention of Cytomegalovirus (CMV) of the Eyes and Disease of the Stomach and Intestines in Patients With HIV

Gastrointestinal Diseases | HIV Infections | Cytomegalovirus Retinitis

United States
National Institute of Allergy and Infectious Diseases...
Hoffmann-La Roche

Completed

A Phase I Pharmacokinetic and Tolerance Study of 28-Day Regimens of Oral Ganciclovir

HIV Infections | Cytomegalovirus Retinitis

United States
Academisch Medisch Centrum - Universiteit van Amsterdam...
Roche Pharma AG

Completed

Feasibility Study of Chemoradiation, TRAstuzumab and Pertuzumab in Resectable HER2+ Esophageal Carcinoma (TRAP)

Esophageal Carcinoma

Netherlands
University of Southern California
Bristol-Myers Squibb; Sanofi; Roche Global Development

Unknown

Study of Oxaliplatin and Xeloda and Cetuximab as First Line Treatment for Metastatic or Unresectable Gastric or Gastroesophageal Junction Cancer

Gastric Cancer | Esophageal Cancer

United States
University of Göttingen
Roche Pharma AG; Mundipharma Research GmbH & Co KG

Completed

Rituximab and Bendamustine in Very Elderly Patients or Elderly Medically Non Fit Patients With Aggressive B-cell Lymphoma (B-R-ENDA)

Aggressive Lymphoma

Germany
Dana-Farber Cancer Institute
National Cancer Institute (NCI); Roche Pharma AG

Completed

Capecitabine For Nasopharyngeal Cancer

Head and Neck Cancer

United States
Hospital for Special Surgery, New York
Roche Pharma AG; Genentech, Inc.

Terminated

Rituximab for the Otolaryngologic Manifestations of Granulomatosis With Polyangiitis (RENTGPA)

Granulomatosis With Polyangiitis (Wegener's Granulomatosis)

United States
Centre Francois Baclesse
Hoffmann-La Roche; Groupe Français de Pneumo-Cancérologie

Terminated

A Multicenter Randomized Phase III Study Comparing Second-line Treatment With Chemotherapy Associated or Not to Erlotinib in NSCLC Patients With Secondary Resistance to TKI-EGFR (FLARE)

NSCLC Patients With EGFR Activating Mutation

France
University of Alberta
Eli Lilly and Company; Sanofi; Hoffmann-La Roche

Completed

Which Therapy for Acute Heart Attacks? (The WEST Study)

Myocardial Infarction

Canada
H. Lee Moffitt Cancer Center and Research Institute
Roche Pharma AG

Terminated

Trial for Microarray Analysis of Colon Cancer Outcome-A (MACCO-A)

Adenocarcinoma | Colon Cancer

United States
Assistance Publique - Hôpitaux de Paris
French Society of Rheumatology; Roche Chugai

Completed

Interest of a Standardized Monitoring of Rheumatoid Arthritis: The COMEDRA Trial (COMEDRA)

Rheumatoid Arthritis

France
Hoosier Cancer Research Network
Sanofi; Hoffmann-La Roche; Walther Cancer Institute

Completed

Capecitabine and Oxaliplatin in Treating Patients With Metastatic Breast Cancer

Metastatic Breast Cancer

United States

Clinical Trials Sponsored by Rachel Lieberman

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in China

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations